HPM Partners LLC lifted its holdings in CVS Health Corp (NYSE:CVS) by 5.4% during the second quarter, Holdings Channel reports. The institutional investor owned 68,727 shares of the pharmacy operator’s stock after buying an additional 3,521 shares during the period. HPM Partners LLC’s holdings in CVS Health were worth $4,423,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of the company. Cozad Asset Management Inc. bought a new position in CVS Health during the 2nd quarter valued at about $2,791,000. Moneta Group Investment Advisors LLC grew its holdings in CVS Health by 1,523.0% during the 2nd quarter. Moneta Group Investment Advisors LLC now owns 39,747 shares of the pharmacy operator’s stock valued at $245,000 after purchasing an additional 37,298 shares during the last quarter. OLD Mutual Customised Solutions Proprietary Ltd. grew its holdings in CVS Health by 6.4% during the 2nd quarter. OLD Mutual Customised Solutions Proprietary Ltd. now owns 34,798 shares of the pharmacy operator’s stock valued at $2,239,000 after purchasing an additional 2,100 shares during the last quarter. Waddell & Reed Financial Inc. grew its holdings in CVS Health by 21.5% during the 2nd quarter. Waddell & Reed Financial Inc. now owns 993,394 shares of the pharmacy operator’s stock valued at $63,925,000 after purchasing an additional 175,725 shares during the last quarter. Finally, Worldquant Millennium Quantitative Strategies LLC bought a new position in CVS Health during the 2nd quarter valued at about $16,079,000. Hedge funds and other institutional investors own 82.71% of the company’s stock.

In other news, EVP Kevin Hourican sold 8,564 shares of the company’s stock in a transaction that occurred on Monday, August 27th. The shares were sold at an average price of $75.00, for a total value of $642,300.00. Following the completion of the sale, the executive vice president now owns 12,135 shares of the company’s stock, valued at approximately $910,125. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 0.53% of the stock is currently owned by corporate insiders.

Several equities analysts recently commented on CVS shares. Citigroup reiterated a “buy” rating and set a $81.00 price target on shares of CVS Health in a report on Monday, July 9th. Leerink Swann set a $80.00 price target on shares of CVS Health and gave the company an “outperform” rating in a report on Thursday, August 9th. ValuEngine upgraded shares of CVS Health from a “strong sell” rating to a “sell” rating in a report on Tuesday, August 28th. Royal Bank of Canada restated a “buy” rating and issued a $90.00 target price on shares of CVS Health in a research note on Wednesday, August 8th. Finally, Morgan Stanley dropped their target price on shares of CVS Health from $88.00 to $80.00 and set an “overweight” rating on the stock in a research note on Tuesday, July 3rd. Two analysts have rated the stock with a sell rating, four have given a hold rating, eleven have given a buy rating and two have assigned a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $86.04.

Shares of CVS stock opened at $78.10 on Tuesday. The company has a debt-to-equity ratio of 1.73, a quick ratio of 1.87 and a current ratio of 2.34. The stock has a market capitalization of $78.30 billion, a price-to-earnings ratio of 11.67, a P/E/G ratio of 1.03 and a beta of 1.00. CVS Health Corp has a one year low of $60.14 and a one year high of $84.00.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, August 8th. The pharmacy operator reported $1.69 EPS for the quarter, topping the Zacks’ consensus estimate of $1.61 by $0.08. The business had revenue of $46.71 billion for the quarter, compared to the consensus estimate of $46.34 billion. CVS Health had a net margin of 1.61% and a return on equity of 18.25%. The company’s revenue for the quarter was up 2.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.33 EPS. equities analysts forecast that CVS Health Corp will post 7.05 EPS for the current fiscal year.

CVS Health Profile

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.

Featured Story: Average Daily Trade Volume Explained

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.